Bailiang Li

1.6k total citations · 1 hit paper
25 papers, 994 citations indexed

About

Bailiang Li is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Bailiang Li has authored 25 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Bailiang Li's work include Cancer Immunotherapy and Biomarkers (6 papers), Radiomics and Machine Learning in Medical Imaging (4 papers) and Ferroptosis and cancer prognosis (4 papers). Bailiang Li is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Radiomics and Machine Learning in Medical Imaging (4 papers) and Ferroptosis and cancer prognosis (4 papers). Bailiang Li collaborates with scholars based in China, United States and Canada. Bailiang Li's co-authors include Ruijiang Li, Yi Cui, Maximilian Diehn, John B. Sunwoo, Dhanya K. Nambiar, Jia Wu, Xiaoli Sun, Yuming Jiang, Allison W. Kurian and Guohong Cao and has published in prestigious journals such as PLoS ONE, Radiology and Clinical Cancer Research.

In The Last Decade

Bailiang Li

25 papers receiving 983 citations

Hit Papers

Development and Validation of an Individualized Immune Pr... 2017 2026 2020 2023 2017 100 200 300

Peers

Bailiang Li
Robin Edwards United States
Craig Barker United Kingdom
Hui Zeng China
Ahrong Kim South Korea
Francesca Khani United States
Marc A. Attiyeh United States
Bailiang Li
Citations per year, relative to Bailiang Li Bailiang Li (= 1×) peers Wenchao Gu

Countries citing papers authored by Bailiang Li

Since Specialization
Citations

This map shows the geographic impact of Bailiang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bailiang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bailiang Li more than expected).

Fields of papers citing papers by Bailiang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bailiang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bailiang Li. The network helps show where Bailiang Li may publish in the future.

Co-authorship network of co-authors of Bailiang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Bailiang Li. A scholar is included among the top collaborators of Bailiang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bailiang Li. Bailiang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Yuming, Bailiang Li, Zhen Han, et al.. (2023). Development and Validation of a Machine Learning Model for Detection and Classification of Tertiary Lymphoid Structures in Gastrointestinal Cancers. JAMA Network Open. 6(1). e2252553–e2252553. 40 indexed citations
2.
Liu, Peidong, Yu Li, Yiming Zhang, et al.. (2022). Calcium-Related Gene Signatures May Predict Prognosis and Level of Immunosuppression in Gliomas. Frontiers in Oncology. 12. 708272–708272. 2 indexed citations
3.
Lundberg, Arian, Bailiang Li, & Ruijiang Li. (2021). B cell-related gene signature and cancer immunotherapy response. British Journal of Cancer. 126(6). 899–906. 12 indexed citations
4.
Zhao, Deze, Mao Zhang, Chuan Hu, et al.. (2021). Alternative Splicing-Based Differences Between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Genes, Immune Microenvironment, and Survival Prognosis. Frontiers in Oncology. 11. 731993–731993. 7 indexed citations
5.
Wang, Haiyue, Yuming Jiang, Bailiang Li, et al.. (2020). Single-Cell Spatial Analysis of Tumor and Immune Microenvironment on Whole-Slide Image Reveals Hepatocellular Carcinoma Subtypes. Cancers. 12(12). 3562–3562. 26 indexed citations
6.
Li, Bailiang, Yuming Jiang, Guoxin Li, George A. Fisher, & Ruijiang Li. (2020). Natural killer cell and stroma abundance are independently prognostic and predict gastric cancer chemotherapy benefit. JCI Insight. 5(9). 58 indexed citations
7.
Li, Bailiang, Yi Cui, Dhanya K. Nambiar, John B. Sunwoo, & Ruijiang Li. (2019). The Immune Subtypes and Landscape of Squamous Cell Carcinoma. Clinical Cancer Research. 25(12). 3528–3537. 152 indexed citations
8.
Li, Bailiang, et al.. (2019). Genomic and Phenotypic Characterization of the Biosynthesis Pathway of Exopolysaccharides in Streptococcus thermophilus KLDS3.1012. Shipin Kexue / Food Science. 40(6). 136–142. 1 indexed citations
9.
Li, Bailiang, Yi Cui, Xiaoli Sun, et al.. (2018). A Quantitative CT Imaging Signature Predicts Survival and Complements Established Prognosticators in Stage I Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 102(4). 1098–1106. 20 indexed citations
10.
Cui, Yi, Bailiang Li, Erqi L. Pollom, Kathleen C. Horst, & Ruijiang Li. (2018). Integrating Radiosensitivity and Immune Gene Signatures for Predicting Benefit of Radiotherapy in Breast Cancer. Clinical Cancer Research. 24(19). 4754–4762. 51 indexed citations
11.
Wu, Jia, Yi Cui, Xiaoli Sun, et al.. (2017). Unsupervised Clustering of Quantitative Image Phenotypes Reveals Breast Cancer Subtypes with Distinct Prognoses and Molecular Pathways. Clinical Cancer Research. 23(13). 3334–3342. 77 indexed citations
13.
Cui, Yi, Xiaoli Sun, Bailiang Li, et al.. (2017). Prognostic value and molecular correlates of a CT image-based quantitative pleural contact index in early stage NSCLC. European Radiology. 28(2). 736–746. 14 indexed citations
14.
Li, Bailiang, Yi Cui, Maximilian Diehn, & Ruijiang Li. (2017). Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non–Small Cell Lung Cancer. JAMA Oncology. 3(11). 1529–1529. 339 indexed citations breakdown →
15.
Wang, Chunxiao, Songling Zhu, Xiaoyu Wang, et al.. (2015). Complete genome sequence of Salmonella enterica subspecies arizonae str. RKS2983. Standards in Genomic Sciences. 10(1). 30–30. 10 indexed citations
16.
Li, Bailiang, et al.. (2015). Profile of differentially expressed intratumoral cytokines to predict the immune-polarizing side effects of tamoxifen in breast cancer treatment.. PubMed. 5(2). 726–37. 8 indexed citations
18.
Zhou, Xianxiao, Bailiang Li, Yuannv Zhang, et al.. (2013). Genes Dysregulated to Different Extent or Oppositely in Estrogen Receptor-Positive and Estrogen Receptor-Negative Breast Cancers. PLoS ONE. 8(7). e70017–e70017. 6 indexed citations
19.
Zhou, Xianxiao, Bailiang Li, Yuannv Zhang, et al.. (2013). A relative ordering-based predictor for tamoxifen-treated estrogen receptor-positive breast cancer patients: multi-laboratory cohort validation. Breast Cancer Research and Treatment. 142(3). 505–514. 14 indexed citations
20.
Xu, Dacheng & Bailiang Li. (2009). A pseudo-random sequence fingerprint key algorithm based on fuzzy vault. 2421–2425. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026